World Investment Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.8M Buy
44,423
+204
+0.5% +$30.6K 0.11% 208
2026
Q1
$6.75M Sell
44,219
-5,995
-12% -$919K 0.11% 210
2025
Q4
$6.92M Buy
50,214
+5,719
+13% +$749K 0.11% 210
2025
Q3
$5.71M Buy
44,495
+1,738
+4% +$212K 0.12% 193
2025
Q2
$5.17M Buy
42,757
+1,286
+3% +$145K 0.12% 200
2025
Q1
$4.62M Buy
41,471
+4,542
+12% +$484K 0.12% 202
2024
Q4
$3.59M Buy
36,929
+3,258
+10% +$347K 0.1% 236
2024
Q3
$3.87M Buy
+33,671
New +$3.82M 0.12% 193

Other funds holding NVS

World Investment Advisors's NVS Position: Q2 2026 in Review

World Investment Advisors increased its Novartis (NVS) stake by 0.46% in Q2 2026, buying an estimated $30.6K and bringing the position to 44,423 shares worth $6.8M. The position accounts for 0.11% of the portfolio, ranked #208.

World Investment Advisors first reported a position in NVS in Q3 2024 and has held it in 8 quarters since. The position peaked at $6.92M in Q4 2025. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • World Investment Advisors held 44,423 shares of Novartis worth $6.8M as of Q2 2026.
  • World Investment Advisors bought 204 Novartis shares in Q2 2026, an estimated $30.6K.
  • Novartis made up 0.11% of World Investment Advisors's portfolio in Q2 2026, its #208 holding.
  • World Investment Advisors first reported a position in Novartis in Q3 2024 and has held it in 8 quarters since.
  • World Investment Advisors's Novartis position peaked at $6.92M in Q4 2025.
  • 1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on World Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.